{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T04:31:50Z","timestamp":1783744310057,"version":"3.55.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Intramural Research","award":["24-11"],"award-info":[{"award-number":["24-11"]}]},{"name":"Intramural Research","award":["27-1"],"award-info":[{"award-number":["27-1"]}]},{"name":"Intramural Research","award":["27-6"],"award-info":[{"award-number":["27-6"]}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"crossref","award":["25253075"],"award-info":[{"award-number":["25253075"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"crossref","award":["15K19715"],"award-info":[{"award-number":["15K19715"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.jad.2017.09.035","type":"journal-article","created":{"date-parts":[[2017,9,28]],"date-time":"2017-09-28T01:15:40Z","timestamp":1506561340000},"page":"155-162","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Cerebrospinal fluid D-serine concentrations in major depressive disorder negatively correlate with depression severity"],"prefix":"10.1016","volume":"226","author":[{"given":"Sayuri","family":"Ishiwata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kotaro","family":"Hattori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daimei","family":"Sasayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiya","family":"Teraishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoko","family":"Miyakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuuki","family":"Yokota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Matsumura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Nishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Kunugi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2017.09.035_bib1","series-title":"Diagnostic and Statistical Manual Of Mental Disorders: DSM-IV","author":"American Psychiatric Association","year":"1994"},{"issue":"1","key":"10.1016\/j.jad.2017.09.035_bib2","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1056\/NEJMra073096","article-title":"Major depressive disorder","volume":"358","author":"Belmaker","year":"2008","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.jad.2017.09.035_bib3","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","article-title":"Antidepressant effects of ketamine in depressed patients","volume":"47","author":"Berman","year":"2000","journal-title":"Biol. Psychiatry"},{"issue":"2\u20133","key":"10.1016\/j.jad.2017.09.035_bib4","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/BF01245227","article-title":"Dopamine and depression","volume":"91","author":"Brown","year":"1993","journal-title":"J. Neural Transm. Gen. Sect."},{"key":"10.1016\/j.jad.2017.09.035_bib5","first-page":"61","article-title":"Depression: the case for a monoamine deficiency","author":"Delgado","year":"2000","journal-title":"J. Clin. Psychiatry"},{"issue":"3","key":"10.1016\/j.jad.2017.09.035_bib6","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/nm.4050","article-title":"Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants","volume":"22","author":"Duman","year":"2016","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.jad.2017.09.035_bib7","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1001\/archpsyc.64.3.327","article-title":"The role of dopamine in the pathophysiology of depression","volume":"64","author":"Dunlop","year":"2007","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2017.09.035_bib8","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"2","key":"10.1016\/j.jad.2017.09.035_bib9","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/j.1471-4159.1993.tb03219.x","article-title":"Endogenous D-serine in rat brain: n-methyl-d-aspartate receptor-related distribution and aging","volume":"60","author":"Hashimoto","year":"1993","journal-title":"J. Neurochem."},{"issue":"3","key":"10.1016\/j.jad.2017.09.035_bib10","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/0306-4522(94)00597-X","article-title":"Extracellular concentration of endogenous free D-serine in the rat brain as revealed by in vivo microdialysis","volume":"66","author":"Hashimoto","year":"1995","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.jad.2017.09.035_bib11","doi-asserted-by":"crossref","first-page":"72","DOI":"10.9758\/cpn.2014.12.1.72","article-title":"The R-stereoisomer of ketamine as an alternative for ketamine for treatment-resistant major depression","volume":"12","author":"Hashimoto","year":"2014","journal-title":"Clin. Psychopharmacol. Neurosci."},{"issue":"3","key":"10.1016\/j.jad.2017.09.035_bib12","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1017\/neu.2015.59","article-title":"Increased serum levels of serine enantiomers in patients with depression","volume":"28","author":"Hashimoto","year":"2016","journal-title":"Acta Neuropsychiatr."},{"issue":"3","key":"10.1016\/j.jad.2017.09.035_bib13","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1017\/S1461145712000910","article-title":"A randomized add-on trial of high-dose D-cycloserine for treatment-resistant depression","volume":"16","author":"Heresco-Levy","year":"2013","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"6","key":"10.1016\/j.jad.2017.09.035_bib14","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1017\/S1461145712001484","article-title":"Modulation of extracellular d-serine content by calcium permeable AMPA receptors in rat medial prefrontal cortex as revealed by in vivo microdialysis","volume":"16","author":"Ishiwata","year":"2013","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"11","key":"10.1016\/j.jad.2017.09.035_bib15","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1007\/s00702-006-0517-3","article-title":"Evidence for involvement of glial cell activity in the control of extracellular D-serine contents in the rat brain","volume":"113","author":"Kanematsu","year":"2006","journal-title":"J. Neural Transm."},{"issue":"1","key":"10.1016\/j.jad.2017.09.035_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0006-3223(92)90137-O","article-title":"Role of the dopaminergic system in depression","volume":"32","author":"Kapur","year":"1992","journal-title":"Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.jad.2017.09.035_bib17","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/j.1471-4159.2011.07313.x","article-title":"Transport systems of serine at the brain barriers and in brain parenchymal cells","volume":"118","author":"Kasai","year":"2011","journal-title":"J. Neurochem."},{"issue":"3","key":"10.1016\/j.jad.2017.09.035_bib18","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0197-0186(94)00125-E","article-title":"Dizocilpine (MK-801) elicits a tetrodotoxin-sensitive increase in extracellular release of dopamine in rat medial frontal cortex","volume":"26","author":"Kashiwa","year":"1995","journal-title":"Neurochem. Int."},{"issue":"7215","key":"10.1016\/j.jad.2017.09.035_bib19","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1038\/nature07455","article-title":"The molecular neurobiology of depression","volume":"455","author":"Krishnan","year":"2008","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.jad.2017.09.035_bib20","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.biopsych.2013.03.026","article-title":"Rapid-acting glutamatergic antidepressants: the path to ketamine and beyond","volume":"73","author":"Krystal","year":"2013","journal-title":"Biol. Psychiatry"},{"issue":"5994","key":"10.1016\/j.jad.2017.09.035_bib21","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1126\/science.1190287","article-title":"mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists","volume":"329","author":"Li","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.jad.2017.09.035_bib22","doi-asserted-by":"crossref","first-page":"e561","DOI":"10.1038\/tp.2015.52","article-title":"D-serine levels in Alzheimer's disease: implications for novel biomarker development","volume":"5","author":"Madeira","year":"2015","journal-title":"Transl. Psychiatry"},{"issue":"1","key":"10.1016\/j.jad.2017.09.035_bib23","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1159\/000119166","article-title":"Increased plasma serine concentrations in depression","volume":"31","author":"Maes","year":"1995","journal-title":"Neuropsychobiology"},{"issue":"6","key":"10.1016\/j.jad.2017.09.035_bib24","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.pnpbp.2006.03.036","article-title":"Correlation between plasma levels of glutamate, alanine and serine with severity of depression","volume":"30","author":"Mitani","year":"2006","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.jad.2017.09.035_bib25","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00213-014-3669-0","article-title":"D-serine plasma concentration is a potential biomarker of (R,S)-ketamine antidepressant response in subjects with treatment-resistant depression","volume":"232","author":"Moaddel","year":"2015","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jad.2017.09.035_bib26","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/1742-2094-10-142","article-title":"Neurovascular unit dysfunction with blood-brain barrier hyperpermeability contributes to major depressive disorder: a review of clinical and experimental evidence","volume":"10","author":"Najjar","year":"2013","journal-title":"J. Neuroinflamm."},{"issue":"4","key":"10.1016\/j.jad.2017.09.035_bib27","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/(SICI)1098-2396(199604)22:4<304::AID-SYN2>3.0.CO;2-F","article-title":"Differential effects of phencyclidine and methamphetamine on dopamine metabolism in rat frontal cortex and striatum as revealed by in vivo dialysis","volume":"22","author":"Nishijima","year":"1996","journal-title":"Synapse"},{"issue":"5","key":"10.1016\/j.jad.2017.09.035_bib28","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/nrd2462","article-title":"Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders","volume":"7","author":"Sanacora","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"issue":"Suppl. 20","key":"10.1016\/j.jad.2017.09.035_bib29","first-page":"22","article-title":"The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10","volume":"59","author":"Sheehan","year":"1998","journal-title":"J. Clin. Psychiatry"},{"issue":"1","key":"10.1016\/j.jad.2017.09.035_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1461145703003900","article-title":"Plasma glycine and serine levels in schizophrenia compared to normal controls and major depression: relation to negative symptoms","volume":"7","author":"Sumiyoshi","year":"2004","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"3","key":"10.1016\/j.jad.2017.09.035_bib31","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0165-0173(83)90005-X","article-title":"Dopamine and depression: a review of recent evidence. I. Empirical studies","volume":"287","author":"Willner","year":"1983","journal-title":"Brain Res."},{"issue":"3","key":"10.1016\/j.jad.2017.09.035_bib32","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0165-0173(83)90007-3","article-title":"Dopamine and depression: a review of recent evidence. III. The effects of antidepressant treatments","volume":"287","author":"Willner","year":"1983","journal-title":"Brain Res."},{"issue":"3","key":"10.1016\/j.jad.2017.09.035_bib33","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0165-0173(83)90006-1","article-title":"Dopamine and depression: a review of recent evidence. II.\u00a0Theoretical approaches","volume":"287","author":"Willner","year":"1983","journal-title":"Brain Res."},{"key":"10.1016\/j.jad.2017.09.035_bib34","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/ijnp\/pyv124","article-title":"Effects of low-dose and very low-dose ketamine among patients with major depression: a systematic review and meta-analysis","volume":"19","author":"Xu","year":"2016","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"9","key":"10.1016\/j.jad.2017.09.035_bib35","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1007\/s00213-014-3543-0","article-title":"Rapid antidepressant effects and abuse liability of ketamine","volume":"231","author":"Yang","year":"2014","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jad.2017.09.035_bib36","doi-asserted-by":"crossref","first-page":"e632","DOI":"10.1038\/tp.2015.136","article-title":"R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects","volume":"5","author":"Yang","year":"2015","journal-title":"Transl. Psychiatry"},{"issue":"53","key":"10.1016\/j.jad.2017.09.035_bib37","doi-asserted-by":"crossref","first-page":"41380","DOI":"10.1074\/jbc.M110.187443","article-title":"Brain-specific Phgdh deletion reveals a pivotal role for L-serine biosynthesis in controlling the level of D-serine, an N-methyl-D-aspartate receptor co-agonist, in adult brain","volume":"285","author":"Yang","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jad.2017.09.035_bib38","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.16m11144","article-title":"Relationships of cerebrospinal fluid monoamine metabolite levels with clinical variable major depressive disorder","author":"Yoon","year":"2017","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2017.09.035_bib39","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.jad.2013.04.028","article-title":"Severity classification on the Hamilton Depression Rating Scale","volume":"150","author":"Zimmerman","year":"2013","journal-title":"J. Affect. Disord."}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032717307759?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032717307759?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,11,29]],"date-time":"2019-11-29T01:21:48Z","timestamp":1574990508000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032717307759"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":39,"alternative-id":["S0165032717307759"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2017.09.035","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cerebrospinal fluid D-serine concentrations in major depressive disorder negatively correlate with depression severity","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2017.09.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}